Progyny, Inc. Stock Price, News & Analysis

Progyny (NASDAQ: PGNY), a leader in women's health and family building solutions, has appointed Elizabeth Bierbower to its Board of Directors. Bierbower brings over 30 years of healthcare industry experience, most recently serving as Chairman and CEO of Friday Health Plans. Her extensive background includes senior leadership roles at Humana, where she served as Segment President, President of the Employer Group Segment, and COO of Specialty Benefits division. She also held key positions at Highmark Blue Cross Blue Shield and Coventry Health Care.

Bierbower currently serves on several boards, including Option Care Health, BlueSprig, Quest Analytics, Paradigm Corp., and Point32Health. CEO Pete Anevski highlighted that her expertise will support Progyny's strategy to deliver increased value to members, clients, and shareholders while expanding reach and impact.

Progyny (NASDAQ: PGNY), a leading women's health and family building solutions provider, has strengthened its Medical Advisory Board with two distinguished appointments. Dr. Gloria Richard-Davis from Morehouse School of Medicine and Dr. Whitney Booker from Columbia University join the board, bringing extensive expertise in women's health and reproductive medicine.

Dr. Richard-Davis is double-board certified in OB-GYN and Reproductive Endocrinology and Infertility, with significant experience in menopause care and health equity. Dr. Booker, double-board certified in OB-GYN and Maternal-Fetal Medicine, specializes in high-risk maternal care and prenatal fetal diagnosis, with NIH-funded research focusing on hypertension and cardiovascular disease in pregnancy.

Progyny (NASDAQ: PGNY), a leading provider of women's health and family building solutions, has announced its participation in the upcoming BofA Securities 2025 Health Care Conference. CEO Pete Anevski and CFO Mark Livingston will engage in a fireside chat on May 14, 2025, at 3:00 PM PT / 6:00 PM ET. Investors and interested parties can access both the live audiocast and replay through the Events and Presentations section on Progyny's investor relations website at investors.progyny.com.

Progyny (Nasdaq: PGNY), a global leader in women's health and family building, has scheduled its first quarter 2025 financial results announcement for Thursday, May 8, 2025, after market close. The company will host a conference call at 4:45 p.m. ET (1:45 p.m. PT) to discuss the results.

Participants can join the call using the following details:

• US participants: 1.866.825.7331
• International participants: 1.973.413.6106
• Passcode: 265484

Progyny (NASDAQ: PGNY), a leader in women's health and family building, has announced two key executive appointments to support its growth and innovation strategy. Melissa Cummings joins as the company's first Chief Operating Officer (COO) and Geoffrey Clapp as its first Chief Product Officer (CPO).

Cummings brings 30 years of healthcare experience, most recently serving as Executive Vice President and Chief Customer Officer at Blue Cross & Blue Shield of Rhode Island. Clapp, with over two decades in healthcare technology, previously held the position of Senior Vice President and Head of Strategy at Optum Health Solutions.

The appointments come as Progyny experiences significant growth, now serving more than 530 employers with 6.7 million contracted lives. The company has expanded its services to include Parent and Child Well-being programs and doula support, positioning itself as a comprehensive solution for reproductive health care.

Progyny (Nasdaq: PGNY), a leader in women's health and family building solutions, announces multiple events for National Infertility Awareness Week (NIAW) and Canadian Fertility Awareness Week (CFAW) from April 20-26, 2025.

Key events include:

• April 21: Nasdaq Stock Market Opening Bell ceremony and Empire State Building lighting in orange
• April 22: 'Infertility Unfiltered' Panel Event in New York and 'Light the Night' Event in Chicago
• April 24: CN Tower lighting in green for CFAW in Toronto

The campaign features advocates Jessi and Alessio Pasini, and Demi and Tom Schweers sharing their fertility journeys. Progyny is partnering with RESOLVE: The National Infertility Association and Fertility Matters Canada to raise awareness about fertility care accessibility and reduce stigma associated with infertility, which affects one in six people trying to conceive.

Progyny (NASDAQ: PGNY) and The Broken Brown Egg have announced their fourth annual Awareness, Hope, and Activism (AHA) Grant for 2025, aimed at supporting BIPOC individuals and couples in family building. The partnership addresses systemic barriers including financial obstacles, health disparities, and social stigmas in fertility care.

Grant recipients will receive comprehensive support including:

• Financial assistance for fertility treatments
• Enhanced medication support through Alto Pharmacy with same-day delivery options
• Unlimited access to a dedicated Progyny Patient Care Advocate
• Clinical education and emotional support throughout their journey

The grant application period runs from April 8 to May 12, 2025, open to U.S. citizens and legal residents aged 18-45. Winners will be selected by a panel of BIPOC infertility advocates and physicians, with announcements scheduled for May 19.

Progyny (NASDAQ: PGNY) announces the expansion of its maternal health services by introducing doula support, both in-person and virtual. The company has partnered with Pacify, a leading maternity care solutions provider, to enhance its comprehensive maternal offerings.

The new doula services aim to address pregnancy, childbirth, and perinatal conditions, which represent a significant portion of employer health spending in the U.S. Members will be matched with specialty-trained, certified doulas based on their care needs and demographic preferences.

Research indicates that doula support may help:

• Reduce C-section rates
• Lower NICU complications
• Decrease maternal health barriers
• Improve overall birthing experience

The service is integrated into Progyny's Pregnancy and Postpartum program, offering support throughout the pregnancy journey, including prenatal care, labor support, lactation assistance, postpartum care, and miscarriage support.